NCT05046002View on ClinicalTrials.gov

COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

August 11, 2021

Primary Completion Date

December 30, 2025

Study Completion Date

December 31, 2026

Conditions
MyocarditisPericarditis
Trial Locations (1)

K1Y4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
lead

Ottawa Heart Institute Research Corporation

OTHER